Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Inventories | 17,209 | 15,339 | 14,381 | 8,269 | N/A |
| TOTAL | $18,309 | $18,039 | $17,082 | $10,969 | $41 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 0 | 49,153 |
| Other Non-Current Assets | 73,400 | 73,400 | 73,400 | 73,400 | 0 |
| TOTAL | $73,400 | $73,400 | $73,400 | $73,400 | $49,153 |
| Total Assets | $91,709 | $91,439 | $90,482 | $84,369 | $49,194 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,464 | 4,942 | 2,896 | 589 | 870 |
| Accounts payable and accrued liabilities | 37,067 | 36,076 | 34,275 | 32,112 | 0 |
| Accrued Expenses | 8,459 | 8,722 | 6,229 | N/A | 491 |
| TOTAL | $52,990 | $49,740 | $43,400 | $32,700 | $3,081 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,800 | 3,800 | 3,800 | 3,800 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 49,153 |
| TOTAL | $6,321 | $6,057 | $5,792 | $5,528 | $49,153 |
| Total Liabilities | $59,311 | $55,797 | $49,192 | $38,229 | $52,234 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,371 | 71,552 | 71,552 | 71,552 | 2,355 |
| Common Shares | 7 | 7 | 7 | 7 | 0 |
| Retained earnings | -59,043 | -53,673 | -45,938 | -39,279 | -3,040 |
| TOTAL | $32,398 | $35,643 | $41,290 | $46,140 | $-3,040 |
| Total Liabilities And Equity | $91,709 | $91,439 | $90,482 | $84,369 | $49,194 |